112 related articles for article (PubMed ID: 28139690)
1. SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.
Ten LC; Chin YM; Tai MC; Chin EF; Lim YY; Suthandiram S; Chang KM; Ong TC; Bee PC; Mohamed Z; Gan GG; Ng CC
Sci Rep; 2017 Jan; 7():41400. PubMed ID: 28139690
[TBL] [Abstract][Full Text] [Related]
2. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami HO; Humphreys K; Liu J
PLoS Genet; 2011 Apr; 7(4):e1001378. PubMed ID: 21533074
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
Wang SS; Abdou AM; Morton LM; Thomas R; Cerhan JR; Gao X; Cozen W; Rothman N; Davis S; Severson RK; Bernstein L; Hartge P; Carrington M
Blood; 2010 Jun; 115(23):4820-3. PubMed ID: 20385791
[TBL] [Abstract][Full Text] [Related]
5. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of genome-wide association studies of follicular lymphoma.
Skibola CF; Conde L; Foo JN; Riby J; Humphreys K; Sillé FC; Darabi H; Sanchez S; Hjalgrim H; Liu J; Bracci PM; Smedby KE
BMC Genomics; 2012 Oct; 13():516. PubMed ID: 23025665
[TBL] [Abstract][Full Text] [Related]
7. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
8. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
9. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue MH; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami HO; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquières H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Cancer Res; 2018 Jul; 78(14):4086-4096. PubMed ID: 29735552
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma-protective HLA class II variants correlate with increased HLA-DQB1 protein expression.
Sillé FC; Conde L; Zhang J; Akers NK; Sanchez S; Maltbaek J; Riby JE; Smith MT; Skibola CF
Genes Immun; 2014 Mar; 15(2):133-6. PubMed ID: 24304973
[TBL] [Abstract][Full Text] [Related]
11. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
12. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
Wang SS; Menashe I; Cerhan JR; Cozen W; Severson RK; Davis S; Hutchinson A; Rothman N; Chanock SJ; Bernstein L; Hartge P; Morton LM
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):42-9. PubMed ID: 21148756
[TBL] [Abstract][Full Text] [Related]
13. Risk of genome-wide association study-identified genetic variants for non-Hodgkin lymphoma in a Chinese population.
Qiao Y; Zhou Y; Wu C; Zhai K; Han X; Chen J; Tian X; Chang J; Lu Z; Zhang B; Yu D; Yao J; Shi Y; Tan W; Lin D
Carcinogenesis; 2013 Jul; 34(7):1516-9. PubMed ID: 23455380
[TBL] [Abstract][Full Text] [Related]
14. HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.
Sayad A; Akbari MT; Mehdizadeh M; Taheri M; Hajifathali A
Iran J Immunol; 2014 Dec; 11(4):269-74. PubMed ID: 25549594
[TBL] [Abstract][Full Text] [Related]
15. Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population.
Lim YY; Chin YM; Tai MC; Fani S; Chang KM; Ong TC; Bee PC; Gan GG; Ng CC
Leuk Lymphoma; 2015 Jan; 56(1):163-8. PubMed ID: 24684230
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
[TBL] [Abstract][Full Text] [Related]
17. HLA homozygosity is associated with Non-Hodgkin lymphoma.
Roark CL; Ho BE; Aubrey MT; Anobile C; Israeli S; Phang TL; Braxton D; Ho AP; Freed BM
Hum Immunol; 2022 Oct; 83(10):730-735. PubMed ID: 35953408
[TBL] [Abstract][Full Text] [Related]
18. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.
De Re V; Caggiari L; Monti G; Libra M; Spina M; Dolcetti R; De Zorzi M; Racanelli V; Crovatto M; Toffoli G
Tissue Antigens; 2010 Feb; 75(2):127-35. PubMed ID: 20002609
[TBL] [Abstract][Full Text] [Related]
19. A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases.
Conde L; Bracci PM; Halperin E; Skibola CF
Genomics; 2011 Jul; 98(1):9-14. PubMed ID: 21439368
[TBL] [Abstract][Full Text] [Related]
20. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.
Aissani B; Ogwaro KM; Shrestha S; Tang J; Breen EC; Wong HL; Jacobson LP; Rabkin CS; Ambinder RF; Martinez-Maza O; Kaslow RA
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):170-9. PubMed ID: 19654554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]